Showing results (1371-1380 of 2,037) with videos related to
Sort By:
Pageof 204
Nuklearmedizin. Nuclear Medicine|October 1, 1996
[Volume reduction of the thyroid after radioiodine therapy in patients with autonomous goiter and Basedow's goiter]B Dederichs, R Otte, J E Klink, et al.Nuklearmedizin. Nuclear Medicine|October 1, 1996
[Increase in TSH levels in thyroid carcinoma patients after withdrawal of suppressive levothyroxine medication]S Hackländer, E Voth, H SchichaNuklearmedizin. Nuclear Medicine|October 1, 1996
[Relationship between properties of 131I therapy and radioiodine kinetics]K Schomäcker, U Wellner, K Scheidhauer, et al.Nuklearmedizin. Nuclear Medicine|December 1, 1996
Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesionsP Lind, H J Gallowitsch, D Kogler, et al.Nuklearmedizin. Nuclear Medicine|December 1, 1996
Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary resultsH J Gallowitsch, E Kresnik, P Mikosch, et al.Nuklearmedizin. Nuclear Medicine|October 15, 1998
[First results of radioiodine therapy of multifocal and disseminated thyroid gland autonomy and use of a TcTUs-adapted dose concept]C Oexle, M Reinhardt, E MoserNuklearmedizin. Nuclear Medicine|October 15, 1998
[Individual calculation of the minimal effective levothyroxine dose in prolonged suppression tests]T Rink, H J Schroth, L H Holle, et al.Nuklearmedizin. Nuclear Medicine|October 15, 1998
[Chest X ray: routine indication in the follow-up of differentiated thyroid cancer?]J Lorenzen, M Beese, J Mester, et al.Nuklearmedizin. Nuclear Medicine|April 1, 1997
[Radioiodine therapy of small, solitary autonomous adenomas]D Steiner, R BauerNuklearmedizin. Nuclear Medicine|April 1, 1997
[Impact of pretreatment variables on the outcome of standardized 131I therapy with 150 Gray in Graves' disease]J Pfeilschifter, H Elser, S Haufe, et al.Pageof 204